Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 77 entries
View as:

A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study

Phase: N/A Priority: Normal
NCT ID: NCT00128830 Org: User:
Start: 06/30/05 End: 08/31/08 Due: 08/31/09

Innovation-TiFP4-C101: A Study to Evaluate the Pharmacokinetics of TMC114 and TMC41629 After a Single Oral Dose of 2 Controlled-release Coformulations as Compared to an Immediate-release Coformulation of TMC114/TMC41629

Phase: N/A Priority: Normal
NCT ID: NCT00854204 Org: User:
Start: 11/30/08 End: 01/31/09 Due: 01/31/10

TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00740389 Org: User:
Start: 09/30/08 End: 01/31/09 Due: 01/31/10

A Study of TMC435 in Combination With Pegylated Interferon Alp\Fa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00882908 Org: User:
Start: 06/30/09 End: 04/30/11 Due: 04/30/12

A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00915655 Org: User:
Start: 07/31/09 End: 03/31/11 Due: 03/31/12

TMC435-TiDP16-C112 - Interaction Trial With Antidepressants

Phase: N/A Priority: Normal
NCT ID: NCT01090700 Org: User:
Start: 05/31/10 End: 09/30/10 Due: 09/30/11

TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial

Phase: N/A Priority: Normal
NCT ID: NCT00111280 Org: User:
Start: 09/30/04 End: 03/31/07 Due: 03/31/08

TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00665847 Org: User:
Start: 11/30/08 End: 08/31/11 Due: 08/31/12

TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT00744809 Org: User:
Start: 08/31/08 End: 01/31/09 Due: 01/31/10

TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00412646 Org: User:
Start: 06/30/02 End: 11/30/06 Due: 11/30/07

An Open-label Trial With TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216).

Phase: N/A Priority: Normal
NCT ID: NCT00359021 Org: User:
Start: 06/30/06 End: 01/31/12 Due: 01/31/13

A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus

Phase: N/A Priority: Normal
NCT ID: NCT01479881 Org: User:
Start: 10/31/11 End: 12/31/11 Due: 12/31/12

TMC278-TiDP6-C153 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC278 and Raltegravir

Phase: N/A Priority: Normal
NCT ID: NCT01288755 Org: User:
Start: 02/28/11 End: 05/31/11 Due: 05/31/12

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Phase: N/A Priority: Normal
NCT ID: NCT00540449 Org: User:
Start: 05/31/08 End: 12/31/11 Due: 12/31/12

TMC114-TiDP3-C176 - A Study in Healthy Volunteers Investigating the Bioequivalence Between Two Commercially Available 400-mg Tablets to One New 800-mg Tablet of Darunavir (DRV) in the Presence of Low-dose Ritonavir Under Fed and Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01308658 Org: User:
Start: 01/31/11 End: 05/31/11 Due: 05/31/12

TMC435-TiDP16-C115 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Erythromycin and Between TMC435 and Darunavir/Ritonavir (DRV/r)

Phase: N/A Priority: Normal
NCT ID: NCT01323257 Org: User:
Start: 03/31/11 End: 08/31/11 Due: 08/31/12

TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.

Phase: N/A Priority: Normal
NCT ID: NCT00650832 Org: User:
Start: 10/31/03 End: 07/31/07 Due: 07/31/08

TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT01202825 Org: User:
Start: 04/30/10 End: 11/30/11 Due: 11/30/12

TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State.

Phase: N/A Priority: Normal
NCT ID: NCT00744770 Org: User:
Start: 10/31/08 End: 06/30/09 Due: 06/30/10

A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive Ovysmen

Phase: N/A Priority: Normal
NCT ID: NCT01486004 Org: User:
Start: 11/30/11 End: 01/31/12 Due: 01/31/13

TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration

Phase: N/A Priority: Normal
NCT ID: NCT01134718 Org: User:
Start: 06/30/10 End: 08/31/10 Due: 08/31/11

TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

Phase: N/A Priority: Normal
NCT ID: NCT00255099 Org: User:
Start: 12/31/05 End: 07/31/08 Due: 07/31/09

TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT00767117 Org: User:
Start: 09/30/08 End: 12/31/08 Due: 12/31/09

TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01052883 Org: User:
Start: 03/31/10 End: 07/31/10 Due: 07/31/11

TMC435-TiDP16-C116 - Relative Bioavailability and Food Effect Study

Phase: N/A Priority: Normal
NCT ID: NCT01308606 Org: User:
Start: 03/31/11 End: 06/30/11 Due: 06/30/12